-
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
Study
EGAS00001004544
-
A Multifactorial Tumor and Immune Cell Profile Determines Response to Immune Checkpoint blockade in Melanoma
Study
EGAS00001004548
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma - RNA-seq
Study
EGAS00001004552
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM67 WES
Study
EGAS00001004555
-
Regulatory T cell transcriptomic reprogramming characterizes adverse events by checkpoint inhibitors in solid tumors
Study
EGAS00001004694
-
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard and high risk myeloma
Study
EGAS00001004558
-
RNASeq of PDX and CDX tumours treated with ADC
Study
EGAS00001004562
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma
Study
EGAS00001004564
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM066-WES
Study
EGAS00001004567
-
Single cell RNA sequencing of CD19 CAR T-cell infusion products
Study
EGAS00001004576
-
Whole Exome Sequences from Iberian Roma samples
Study
EGAS00001004599
-
Queensland Melanoma Genomic Biomarker Study
Study
EGAS00001004619
-
Mutational landscape of eccrine porocarcinoma (sweat gland tumour)
Study
EGAS00001004632
-
RNA sequencing of follicular T cell lymphoma
Study
EGAS00001004646
-
Targeted sequencing of Burkitt lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001004649
-
Cerebrospinal fluid circulating tumour DNA allows the characterisation and monitoring of medulloblastoma
Study
EGAS00001004651
-
Tumour gene expression signature in primary melanoma predicts long-term outcomes: A prospective multicentre study
Study
EGAS00001004664
-
Lymphoma Group
Dac
EGAC00001001243
-
Ultraviolet radiation drives mutations in a subset of mucosal melanomas
Study
EGAS00001004697
-
A novel orthotopic patient-derived xenograft model of radiation-induced glioma following medulloblastoma
Study
EGAS00001004709
-
STAT5 is a therapeutically targetable vulnerability in cutaneous T-cell lymphoma
Study
EGAS00001004719
-
Multi Omics of glioma in the the Chinese Glioma Genome Atlas (CGGA) project
Study
EGAS00001004729
-
Identification of rare germline variants in familial multiple myeloma
Study
EGAS00001004734
-
Multi-region whole-exome sequencing of 10 neuroblastoma cases
Study
EGAS00001004735
-
Small molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma (RNAseq dataset)
Study
EGAS00001004748
-
Efficacy of CDK4/6i in preclinical models of malignant pleural mesothelioma
Study
EGAS00001005352
-
Investigate the evolutionary trajectories during invasiveness acquisition in early lung adenocarcinoma
Study
EGAS00001004754
-
Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation
Study
EGAS00001004763
-
Metabolic requirements of the metastasis-initiating tumour cell population using oral squamous cell carcinoma (OSCC) as a model system
Study
EGAS00001004765
-
Overactivation of the IGF signalling pathway in osteosarcoma
Study
EGAS00001004767
-
Rna-Seq Leiomyosarcoma subtypes
Study
EGAS00001004783
-
Integrative multi-omic analyses of malignant pleural mesothelioma
Study
EGAS00001004812
-
Integrated Genomic and Transcriptomic Analysis Reveals Unique Characteristics of Hepatic Metastases and Pro-metastatic Role of Complement C1q in Pancreatic Ductal Adenocarcinoma
Study
EGAS00001004821
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – Whole exome sequencing
Study
EGAS00001004832
-
Comprehensive genomic and transcriptomic analysis of three synchronous primary tumours and a recurrence from a head and neck cancer patient
Study
EGAS00001004857
-
Genomic analysis of a hypermutated gliosarcoma
Study
EGAS00001004864
-
Multiregional sequencing of IDH-WT glioblastoma reveals high genetic heterogeneity and a dynamic evolutionary history
Study
EGAS00001005128
-
Mutational Landscape of Plasmablastic Lymphoma
Study
EGAS00001004906
-
ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells-of-origin
Study
EGAS00001004913
-
Selective Elimination of Immunosuppressive T cells in Patients with Multiple Myeloma
Study
EGAS00001004915
-
Splicing patterns in SF3B1 mutated uveal melanoma generate shared immunogenic tumor-specific neo-epitopes
Study
EGAS00001005226
-
Tissue and plasma RNA from esophageal cancer and precursor lesions
Study
EGAS00001004939
-
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon-based sequencing
Study
EGAS00001004941
-
CASCADE metastatic melanoma study
Study
EGAS00001004950
-
Cell-free DNA TAPS for early cancer detection
Study
EGAS00001004962
-
Assessment of cannabidiol and Δ9-tetrahydrocannabiol in mouse models of medulloblastoma
Study
EGAS00001004963
-
Evolutionary dynamics of neuroblastoma
Study
EGAS00001004990
-
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
Study
EGAS00001005023
-
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity through a pathogenic lipid metabolism-mTOR circuit
Study
EGAS00001005053
-
Genetic analysis of HLA and immune escape genes in Diffuse Large B-cell Lymphoma
Study
EGAS00001005054